83 related articles for article (PubMed ID: 21868456)
41. Non-alcoholic fatty liver: a common manifestation of a metabolic disorder.
Malnick SD; Beergabel M; Knobler H
QJM; 2003 Oct; 96(10):699-709. PubMed ID: 14500857
[No Abstract] [Full Text] [Related]
42. Iron, metabolic syndrome, nonalcoholic fatty liver disease and carotid atherosclerosis.
Mascitelli L; Pezzetta F; Goldstein MR
Atherosclerosis; 2009 Jul; 205(1):39-40. PubMed ID: 19155012
[No Abstract] [Full Text] [Related]
43. Lipotoxicity and glucotoxicity in type 2 diabetes. Effects on development and progression.
Sivitz WI
Postgrad Med; 2001 Apr; 109(4):55-9, 63-4. PubMed ID: 11317469
[TBL] [Abstract][Full Text] [Related]
44. Secondary hyperlipidaemia: beyond the primary debate.
Smellie WS
Ann Clin Biochem; 1994 Jan; 31 ( Pt 1)():85-6. PubMed ID: 8154856
[No Abstract] [Full Text] [Related]
45. Validation of diabetes risk scores for predicting diabetes diagnosed by oral glucose tolerance test.
Li HY; Chang YC; Wei JN; Chuang LM
Diabetes Care; 2010 Feb; 33(2):e26. PubMed ID: 20103552
[No Abstract] [Full Text] [Related]
46. Total body fat distribution as part of multiorgan MR imaging: new tool for risk assessment in the metabolic syndrome?
Lamb HJ
Radiology; 2010 Nov; 257(2):307-8. PubMed ID: 20959542
[No Abstract] [Full Text] [Related]
47. Transient massive hyperlipidaemia in a type 2 diabetic subject.
Vigna GB; Passaro A; Bonomo K; Anfossi G; Fellin R; Trovati M
Intern Emerg Med; 2007 Mar; 2(1):67-70. PubMed ID: 17551694
[No Abstract] [Full Text] [Related]
48. Rate of eating and body weight in patients with type 2 diabetes or hyperlipidaemia.
Takayama S; Akamine Y; Okabe T; Koya Y; Haraguchi M; Miyata Y; Sakai T; Sakura H; Sasaki T
J Int Med Res; 2002; 30(4):442-4. PubMed ID: 12235929
[TBL] [Abstract][Full Text] [Related]
49. [Importance of glucose metabolic characteristics in the pathogenesis of hyperlipidemia in atherosclerosis in people].
Borinskiĭ IuN
Kardiologiia; 1980 Mar; 20(3):111-2. PubMed ID: 7373981
[No Abstract] [Full Text] [Related]
50. Early identification of type 2 diabetes: policy should be aligned with health systems strengthening.
Narayan KM; Chan J; Mohan V
Diabetes Care; 2011 Jan; 34(1):244-6. PubMed ID: 21193623
[No Abstract] [Full Text] [Related]
51. Diabetes mellitus in older adults: underdiagnosis and undertreatment.
Halter JB
J Am Geriatr Soc; 2000 Mar; 48(3):340-1. PubMed ID: 10733066
[No Abstract] [Full Text] [Related]
52. Pediatricians' IQ on RDS, NAFLD, and syndrome X.
Schwartz ID
J Pediatr; 2006 Oct; 149(4):582-3; author reply 583. PubMed ID: 17011346
[No Abstract] [Full Text] [Related]
53. Has the time come for routine imaging studies in diabetes?
Mohan V
Diabetes Technol Ther; 2013 May; 15(5):349-50. PubMed ID: 23634669
[No Abstract] [Full Text] [Related]
54. The bulge, booze, and the liver.
Adams LA; Angulo P
Clin Gastroenterol Hepatol; 2005 Dec; 3(12):1195-7. PubMed ID: 16361044
[No Abstract] [Full Text] [Related]
55. Screening for secondary causes of hyperlipidaemia in general practice. Correct diagnosis needs to be established.
Reynolds TM; Wierzbicki AS; Feher MD
BMJ; 1994 Nov; 309(6965):1373-4; author reply 1374-5. PubMed ID: 7866105
[No Abstract] [Full Text] [Related]
56. Why is hyperlipidaemia important?
Seftel HC
S Afr Med J; 1977 Jul; 52(4):148. PubMed ID: 897881
[No Abstract] [Full Text] [Related]
57. Associations of Triglycerides and Atherogenic Index of Plasma with Brain Structure in the Middle-Aged and Elderly Adults.
Chen X; Bao Y; Zhao J; Wang Z; Gao Q; Ma M; Xie Z; He M; Deng X; Ran J
Nutrients; 2024 Feb; 16(5):. PubMed ID: 38474800
[TBL] [Abstract][Full Text] [Related]
58. Investigating mixed hyperlipidaemia.
Viljoen A; Wierzbicki AS
BMJ; 2011 Aug; 343():d5146. PubMed ID: 21868456
[No Abstract] [Full Text] [Related]
59. Metabolic syndrome and its components in men.
Adriansjah H; Adam JM
Acta Med Indones; 2005; 37(2):66-70. PubMed ID: 20066787
[TBL] [Abstract][Full Text] [Related]
60. The association between masked hypertension and waist circumference as an obesity-related anthropometric index for metabolic syndrome: the Ohasama study.
Asayama K; Sato A; Ohkubo T; Mimura A; Hayashi K; Kikuya M; Yasui D; Kanno A; Hara A; Hirose T; Obara T; Metoki H; Inoue R; Hoshi H; Satoh H; Imai Y
Hypertens Res; 2009 Jun; 32(6):438-43. PubMed ID: 19390540
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
